Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03472157

A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

Prospective Multicentric, Open Label, Randomized Clinical Trial of Superiority, With Two Arms, Comparing Bariatric Surgery to the Recommended Medical Treatment for NASH

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to demonstrate the superiority of bariatric surgery on the disappearance of NASH without worsening of fibrosis in comparison to medical standard treatment in obese patients (35 kg/m² \> BMI ≥ 30 kg/m²) with NASH complicated of advanced fibrosis (F3 and F4 fibrosis grade according to Brunt score).

Conditions

Interventions

TypeNameDescription
OTHERLifestyle therapyLifestyle habits (caloric intake and exercise) + pedometer
PROCEDUREBariatric surgeryTwo different types of bariatric surgery can be proposed: laparoscopic Roux-en-Y Gastric Bypass or a Laparoscopic sleeve gastrectomy

Timeline

Start date
2018-06-20
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2018-03-21
Last updated
2026-04-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03472157. Inclusion in this directory is not an endorsement.